Adertis Healthmark Private Limited

Adertis Healthmark Private Limited

Pharma company manufacturing products since 2015, based in Haryana.
2015 | Ambala, Haryana (India) | Active

Last Updated:

December 07, 2024
HomeCompanyAdertis Healthmark Private Limited

Who are the key members and board of directors at Adertis Healthmark?

Board Members(2)

NameDesignationAppointment DateStatus
Birbal Sharma In Director 15-Sep-2015Current
Sikandar Shaw In Additional Director 07-Mar-2024Current

Financial Performance and Corporate Structure Insights of Adertis Healthmark.

Adertis Healthmark Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 45.68% decrease. The company also saw a substantial fall in profitability, with a 61% decrease in profit. The company's net worth moved up by a moderate rise of 6.61%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-45.68%
Revenue from Operations
-45.72%
Total Assets
11.68%
Profit or Loss
-61.00%
Net Worth
6.61%
EBITDA
6.27%

Charges (Loans)

Open Charges

₹1.12 M

LenderAmountStatus

Central Bank Of India

Creation Date: 08 Jun 2020
₹0.17 MOpen

Central Bank Of India

Creation Date: 30 Dec 2019
₹0.95 MOpen

How Many Employees Work at Adertis Healthmark?

Unlock and access historical data on people associated with Adertis Healthmark, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Adertis Healthmark

Recent activity within the organization

  • Annual General Meeting

    Adertis Healthmark Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Adertis Healthmark Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

    31 Mar 2024

  • Director Appointment

    Sikandar Prasad Shaw was appointed as a Additional Director was appointed as a Additional Director on 07 Mar 2024 & has been associated with this company since 9 months 15 days .

    07 Mar 2024

  • Charges

    A charge with Central Bank Of India amounted to Rs. 0.17 M with Charge ID 100368716 was registered on 08 Jun 2020.

    08 Jun 2020

  • Charges

    A charge with Central Bank Of India amounted to Rs. 0.95 M with Charge ID 100365388 was registered on 30 Dec 2019.

    30 Dec 2019

  • Director Appointment

    Birbal Sharma was appointed as a Director was appointed as a Director on 15 Sep 2015 & has been associated with this company since 9 years 3 months .

    15 Sep 2015

Frequently asked questions

  • Adertis Healthmark Private Limited was incorporated on 15 Sep 2015.

  • The authorized share capital of Adertis Healthmark Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Adertis Healthmark Private Limited.

    • Birbal Sharma
    • Sikandar Prasad Shaw
  • As per Ministry of Corporate Affairs (Mca), the registered address of Adertis Healthmark Private Limited is Ward-1, Brahampuri Colony Hussani Road India, Naraingarh, Haryana, 134203.

  • The corporate identification number (CIN) of Adertis Healthmark Private Limited is U51909HR2015PTC056650 and the company number is 056650 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2021, the revenue trend for Adertis Healthmark Private Limited has fallen by -45.68%.

  • The financial reports for the fiscal year 2021 indicates that The net worth of Adertis Healthmark Private Limited has experienced an upsurge of 6.61%.

  • As per the financial statements for fiscal Year 2021, The total open charges for Adertis Healthmark Private Limited amount to ₹ 1.12 M.

  • The most recent Balance Sheet for Adertis Healthmark Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development